Nanoviricides Stock Price on February 11, 2021
NNVC Stock | USD 1.16 0.02 1.69% |
Below is the normalized historical share price chart for NanoViricides extending back to August 12, 2004. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of NanoViricides stands at 1.16, as last reported on the 18th of April 2024, with the highest price reaching 1.23 and the lowest price hitting 1.15 during the day.
If you're considering investing in NanoViricides Stock, it is important to understand the factors that can impact its price. We consider NanoViricides very risky. NanoViricides has Sharpe Ratio of 0.0551, which conveys that the firm had a 0.0551% return per unit of risk over the last 3 months. We have found thirty technical indicators for NanoViricides, which you can use to evaluate the volatility of the firm. Please verify NanoViricides' Risk Adjusted Performance of 0.0475, downside deviation of 3.19, and Mean Deviation of 2.26 to check out if the risk estimate we provide is consistent with the expected return of 0.18%.
At present, NanoViricides' Other Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Liabilities And Stockholders Equity is expected to grow to about 20.7 M, whereas Total Stockholder Equity is forecasted to decline to about 15.3 M. . As of April 18, 2024, Price Earnings Ratio is expected to decline to -1.47. In addition to that, Price Book Value Ratio is expected to decline to 0.77. NanoViricides Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 26th of October 2005 | 200 Day MA 1.2425 | 50 Day MA 1.2114 | Beta 0.705 |
NanoViricides |
Sharpe Ratio = 0.0551
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | NNVC | |||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
3.26 actual daily | 28 72% of assets are more volatile |
Expected Return
0.18 actual daily | 3 97% of assets have higher returns |
Risk-Adjusted Return
0.06 actual daily | 4 96% of assets perform better |
Based on monthly moving average NanoViricides is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of NanoViricides by adding it to a well-diversified portfolio.
Price Book 1.1825 | Book Value 1.057 | Enterprise Value 8.7 M | Enterprise Value Ebitda (1.08) | Shares Float 11.2 M |
NanoViricides Valuation on February 11, 2021
It is possible to determine the worth of NanoViricides on a given historical date. On February 11, 2021 NanoViricides was worth 1.98 at the beginning of the trading date compared to the closed value of 2.14. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of NanoViricides stock. Still, in general, we apply an absolute valuation method to find NanoViricides' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of NanoViricides where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against NanoViricides' related companies.
Open | High | Low | Close | Volume | |
04/04/2022 | 1.98 | 2.14 | 1.98 | 2.14 | 46,100 |
2.12 | 2.13 | 1.98 | 2.04 | 17,300 |
Backtest NanoViricides | | | NanoViricides History | | | NanoViricides Valuation | Next |
NanoViricides Trading Date Momentum on February 11, 2021
The event impact on price volatility cannot be determined at this time. Please check this event after some time to allow current data to be analyzed.NanoViricides Fundamentals Correlations and Trends
By evaluating NanoViricides' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among NanoViricides' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. NanoViricides financial account trend analysis is a perfect complement when working with valuation or volatility modules.About NanoViricides Stock history
NanoViricides investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for NanoViricides is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in NanoViricides will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing NanoViricides stock prices may prove useful in developing a viable investing in NanoViricides
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 13.4 M | 14 M | |
Net Loss | -7.7 M | -8.1 M |
NanoViricides Quarterly Net Working Capital |
|
NanoViricides Stock Technical Analysis
NanoViricides technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
NanoViricides Period Price Range
Low | April 4, 2022
| High |
1.98 | 2.14 |
NanoViricides April 18, 2024 Market Strength
Market strength indicators help investors to evaluate how NanoViricides stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading NanoViricides shares will generate the highest return on investment. By undertsting and applying NanoViricides stock market strength indicators, traders can identify NanoViricides entry and exit signals to maximize returns
NanoViricides Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for NanoViricides' price direction in advance. Along with the technical and fundamental analysis of NanoViricides Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of NanoViricides to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.0475 | |||
Jensen Alpha | 0.1772 | |||
Total Risk Alpha | (0.04) | |||
Sortino Ratio | 0.0456 | |||
Treynor Ratio | 0.6332 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NanoViricides. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. For information on how to trade NanoViricides Stock refer to our How to Trade NanoViricides Stock guide.You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Complementary Tools for NanoViricides Stock analysis
When running NanoViricides' price analysis, check to measure NanoViricides' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NanoViricides is operating at the current time. Most of NanoViricides' value examination focuses on studying past and present price action to predict the probability of NanoViricides' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NanoViricides' price. Additionally, you may evaluate how the addition of NanoViricides to your portfolios can decrease your overall portfolio volatility.
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
AI Investment Finder Use AI to screen and filter profitable investment opportunities |
Is NanoViricides' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NanoViricides. If investors know NanoViricides will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NanoViricides listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.80) | Return On Assets (0.36) | Return On Equity (0.58) |
The market value of NanoViricides is measured differently than its book value, which is the value of NanoViricides that is recorded on the company's balance sheet. Investors also form their own opinion of NanoViricides' value that differs from its market value or its book value, called intrinsic value, which is NanoViricides' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NanoViricides' market value can be influenced by many factors that don't directly affect NanoViricides' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between NanoViricides' value and its price as these two are different measures arrived at by different means. Investors typically determine if NanoViricides is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NanoViricides' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.